 OrthoSpin CEO Oren Cohen: "The funding will enable us to accelerate our development process and broaden our clinical trials." Photo: Trendlines OrthoSpin Ltd., a portfolio company of The Trendlines Group, has completed an investment round of US$3 million for its smart, robotic external fixation system for orthopedic treatments.
External fixation devices are a common treatment choice for bone lengthening, setting complex fractures, and correcting deformities. Patient compliance challenges and a lack of real-time feedback for physician follow-up present substantial challenges. Currently, effective treatment necessitates that patients manually adjust fixation devices on a daily basis, requiring complicated patient training. This often causes adjustment errors and non-compliance results in poor clinical outcomes. The Trendlines Group, which is listed on the Singapore Exchange, notes that the investment in OrthoSpin -- founded in 2014 -- bears no material value on Trendlines or its assets. |
||||||
See how the OrthoSpin product improves life quality of users -->
The OrthoSpin system makes pre-programmed adjustments automatically and continuously — without the need for patient involvement.
Integrated software enables physicians to chart patient progress, and, when required, immediately adjust treatment programs.
The accurate OrthoSpin system eliminates the need for weekly follow-up and is generally expected to improve patient experience resulting from smaller incremental adjustments with reduced soft tissue damage.
“We are delighted to have this investment and support from JJDC, as we continue the development of OrthoSpin,” said Oren Cohen, CEO of OrthoSpin. “We are confident that this investment will be an important step in bringing OrthoSpin’s system to market.”
